EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group

Industry Body Raises The Alarm Over Energy Costs In Open Letter

Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.

Close up of capsules on a production line
European manufacturing needs support over rising energy costs • Source: Shutterstock

More from Europe

More from Geography